CMV 2012 to be held in San Francisco, California from Monday October 29 through Friday November 2, 2012.
In an effort to efficiently promote the advancement of CMV-based research and to develop novel research, clinical, and public health strategies broadly targeting CMV, the Congenital CMV Conference and the International CMV/Betaherpesvirus Workshop are jointly holding a combined meeting. Entitled CMV 2012, the meeting will be held October 29th to November 2nd, 2012 at the Mission Bay Conference Center in San Francisco, California.
The areas of focus of both the Congenital CMV Conferences and the International CMV/Betaherpesvirus Workshop will be well represented at CMV 2012.
One impetus for CMV 2012 is to provide a cost-effective mechanism for maximizing scientific interactions while minimizing the costs to the attendees. The first part of CMV2012 will emphasize relevant issues of congenital infection, with particular attention on clinical pathogenesis, epidemiology and diagnosis, community awareness and family involvement with congenital CMV disease, novel treatments and clinical trials. In addition, the final session of the first half of the meeting will be devoted to vaccines, antivirals, and therapeutics. This session will overlap with the beginning of the second half of the meeting, which will focus on the molecular virology of CMV with emphasis on aspects of virus-cell interactions, viral replication, antiviral immunity and viral modulation of host immune responses, and transplantation-associated diagnosis/treatment/prevention of CMV disease. We, the organizers, are very excited about the broad exchange of diverse ideas and extensive cross-fertilization that this type of conference will provide. It is our fundamental belief that the cost savings of bringing both conferences together will allow more students, postdoctoral fellows, junior scientists, and clinicians to attend and add to the scientific vitality of CMV 2012.